Eric K. C. Lee

Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience

Darren M.C. Poon, Kuen Chan, S. H. Lee et al. · BMC Urology · 2016 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong

Darren M.C. Poon, Kenneth C.W. Wong, Tim Chan et al. · Clinical Genitourinary Cancer · 2018 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone‐naïve prostate cancer: The first real‐life experience in Asia

Darren M.C. Poon, Tim Chan, Kuen Chan et al. · Asia-Pacific Journal of Clinical Oncology · 2018 · 19 citations · Full text

Medicine, Oncology, Urology +12

Differences in clinical outcome between docetaxel and abiraterone acetate as the first-line treatment in chemo-naïve metastatic castration-resistant prostate cancer patients with or without the ineligible clinical factors of the COU-AA-302 study

Darren M.C. Poon, Kuen Chan, Siu H. Lee et al. · Prostate International · 2017 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +16